2,4-dinitrobenzenesulfonic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2,4-dinitrobenzenesulfonic acid : The arenesulfonic acid that is benzenesulfonic acid with two nitro substituents in the 2- and 4-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 6959 |
| CHEMBL ID | 3303302 |
| CHEBI ID | 53070 |
| SCHEMBL ID | 63183 |
| MeSH ID | M0041160 |
| Synonym |
|---|
| benzenesulfonic acid, 2,4-dinitro- |
| 2,4-dinitrophenylsulfonic acid |
| einecs 201-876-9 |
| kyselina 2,4-dinitrobenzensulfonova [czech] |
| nsc 163960 |
| brn 2147447 |
| 2,4-dinitrobenzenesulphonic acid |
| nsc163960 |
| 2,4-dinitrobenzenesulfonic acid |
| benzenesulfonic acid,4-dinitro- |
| wln: wsqr bnw dnw |
| 89-02-1 |
| kyselina 2,4-dinitrobenzensulfonova |
| nsc-163960 |
| nsc-152110 |
| dinitrobenzenesulfonic acid |
| 2,4-dnbsa |
| dnbsa |
| 2,4-dinitrobenzene sulfonic acid |
| 2,4-dinitrobenzene-1-sulfonic acid |
| 2,4-dinitrobenzene-1-sulphonic acid |
| CHEBI:53070 , |
| 2,4-dinitrobenzene sulphonic acid |
| ovojuakdtooxrf-uhfffaoysa- |
| inchi=1/c6h4n2o7s/c9-7(10)4-1-2-6(16(13,14)15)5(3-4)8(11)12/h1-3h,(h,13,14,15) |
| 3wf0u675g6 , |
| 4-11-00-00213 (beilstein handbook reference) |
| unii-3wf0u675g6 |
| FT-0610203 |
| CHEMBL3303302 |
| SCHEMBL63183 |
| 2,4-dinitrobenzene-sulfonic acid |
| Q27123943 |
| DTXSID00859151 |
| Class | Description |
|---|---|
| arenesulfonic acid | Organic derivatives of sulfonic acid in which the sulfo group is linked directly to carbon of an aryl group. |
| C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 17 (13.71) | 18.7374 |
| 1990's | 8 (6.45) | 18.2507 |
| 2000's | 51 (41.13) | 29.6817 |
| 2010's | 45 (36.29) | 24.3611 |
| 2020's | 3 (2.42) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 125 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| singlet oxygen | [no description available] | medium | 1 | 0 | chalcogen; monoatomic oxygen; nonmetal atom | macronutrient |
| zn(ii)-phthalocyanine | [no description available] | medium | 2 | 0 | metallophthalocyanine; zinc tetrapyrrole | fluorochrome |
| combretastatin | [no description available] | medium | 1 | 0 | ||
| dinitrofluorobenzene | [no description available] | medium | 15 | 0 | C-nitro compound; organofluorine compound | agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent |
| mesalamine | [no description available] | medium | 3 | 0 | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
| metoclopramide | [no description available] | medium | 1 | 0 | benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound | antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic |
| thiophenol | [no description available] | medium | 1 | 0 | aryl thiol | |
| naphthalene | [no description available] | medium | 1 | 0 | naphthalenes; ortho-fused bicyclic arene | apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component |
| benzimidazole | [no description available] | medium | 1 | 0 | benzimidazole; polycyclic heteroarene | |
| mocetinostat | [no description available] | medium | 23 | 0 | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
| adenine | [no description available] | medium | 2 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
| 9-(2-hydroxy-3-nonyl)adenine | [no description available] | medium | 2 | 0 | ||
| 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate | [no description available] | medium | 1 | 0 | purine ribonucleoside triphosphate | |
| malondialdehyde | [no description available] | medium | 2 | 0 | dialdehyde | biomarker |
| tiopronin | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
| 2,4-pentanediol | [no description available] | medium | 1 | 0 | ||
| dinitrochlorobenzene | [no description available] | medium | 6 | 0 | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser |
| carbachol | [no description available] | medium | 1 | 0 | ammonium salt; carbamate ester | cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic |
| adenosine | [no description available] | medium | 2 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
| 2-chloro-n(6)cyclopentyladenosine | [no description available] | medium | 1 | 0 | ||
| 1,3-dipropyl-8-cyclopentylxanthine | [no description available] | medium | 1 | 0 | oxopurine | adenosine A1 receptor antagonist; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
| cysteine | [no description available] | medium | 2 | 0 | cysteinium | fundamental metabolite |
| 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | [no description available] | medium | 2 | 0 | BODIPY compound | |
| nad | [no description available] | medium | 1 | 0 | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite |
| bandrowski's base | [no description available] | medium | 1 | 0 | ||
| sphingosine | [no description available] | medium | 1 | 0 | sphing-4-enine | human metabolite; mouse metabolite |
| oxazoles | [no description available] | medium | 1 | 0 | 1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
| 3-nitrotyrosine | [no description available] | medium | 4 | 0 | 2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid | |
| losartan potassium | [no description available] | medium | 2 | 0 | ||
| tyrosine | [no description available] | medium | 4 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
| allopurinol | [no description available] | medium | 2 | 0 | nucleobase analogue; organic heterobicyclic compound | antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger |
| nadp | [no description available] | medium | 1 | 0 | ||
| hypoxanthine | [no description available] | medium | 1 | 0 | nucleobase analogue; oxopurine; purine nucleobase | fundamental metabolite |
| erythrosine | [no description available] | medium | 1 | 0 | ||
| trinitrobenzenesulfonic acid | [no description available] | medium | 6 | 0 | arenesulfonic acid; C-nitro compound | epitope; explosive; reagent |
| glyceryl 2-arachidonate | [no description available] | medium | 1 | 0 | 2-acylglycerol 20:4; endocannabinoid | human metabolite |
| anandamide | [no description available] | medium | 1 | 0 | endocannabinoid; N-acylethanolamine 20:4 | human blood serum metabolite; neurotransmitter; vasodilator agent |
| arachidonoylserotonin | [no description available] | medium | 1 | 0 | N-acylserotonin; phenols | anti-inflammatory agent; anticonvulsant; antioxidant; capsaicin receptor antagonist; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; human metabolite; signalling molecule |
| n-(2,4-dinitrophenyl)ethylenediamine | [no description available] | medium | 1 | 0 | ||
| ranitidine | [no description available] | medium | 2 | 0 | C-nitro compound; furans; organic sulfide; tertiary amino compound | anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic |
| cimetidine | [no description available] | medium | 2 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
| dinitrobenzenes | [no description available] | medium | 7 | 0 | ||
| p-azobenzenearsonate | [no description available] | medium | 1 | 0 | ||
| oxazolone | [no description available] | medium | 2 | 0 | ||
| sym-trinitrobenzene | [no description available] | medium | 1 | 0 | trinitrobenzene | explosive |
| arachidonic acid | [no description available] | medium | 1 | 0 | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
| benzocaine | [no description available] | medium | 1 | 0 | benzoate ester; substituted aniline | allergen; antipruritic drug; sensitiser; topical anaesthetic |
| framycetin | [no description available] | medium | 1 | 0 | aminoglycoside | allergen; antibacterial drug; Escherichia coli metabolite |
| cyclosporine | [no description available] | medium | 1 | 0 | ||
| pentoxifylline | [no description available] | medium | 1 | 0 | oxopurine | |
| ovalbumin | [no description available] | medium | 1 | 0 | ||
| zinc sulfate | [no description available] | medium | 1 | 0 | metal sulfate; zinc molecular entity | fertilizer |
| terfenadine | [no description available] | medium | 1 | 0 | diarylmethane | |
| ketotifen | [no description available] | medium | 1 | 0 | cyclic ketone; olefinic compound; organic heterotricyclic compound; organosulfur heterocyclic compound; piperidines; tertiary amino compound | anti-asthmatic drug; H1-receptor antagonist |
| warfarin | [no description available] | medium | 1 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
| osthol | [no description available] | medium | 1 | 0 | botanical anti-fungal agent; coumarins | metabolite |
| palmidrol | [no description available] | medium | 1 | 0 | endocannabinoid; N-(long-chain-acyl)ethanolamine; N-(saturated fatty acyl)ethanolamine | anti-inflammatory drug; anticonvulsant; antihypertensive agent; neuroprotective agent |
| n-oleoylethanolamine | [no description available] | medium | 1 | 0 | endocannabinoid; N-(long-chain-acyl)ethanolamine; N-acylethanolamine 18:1 | EC 3.5.1.23 (ceramidase) inhibitor; geroprotector; PPARalpha agonist |
| capsaicin | [no description available] | medium | 4 | 0 | capsaicinoid | non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker |
| capsazepine | [no description available] | medium | 2 | 0 | benzazepine; catechols; monochlorobenzenes; thioureas | capsaicin receptor antagonist |
| transforming growth factor beta | [no description available] | medium | 3 | 0 | ||
| hydrogen sulfide | [no description available] | medium | 2 | 0 | gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride | Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent |
| allyl sulfide | [no description available] | medium | 1 | 0 | organic sulfide | |
| diallyl disulfide | [no description available] | medium | 2 | 0 | organic disulfide | antifungal agent; antineoplastic agent; plant metabolite |
| nitrites | [no description available] | medium | 1 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | human metabolite |
| px 478 | [no description available] | medium | 1 | 0 | ||
| pimagedine | [no description available] | medium | 1 | 0 | guanidines; one-carbon compound | EC 1.14.13.39 (nitric oxide synthase) inhibitor; EC 1.4.3.4 (monoamine oxidase) inhibitor |
| dizocilpine maleate | [no description available] | medium | 1 | 0 | maleate salt; tetracyclic antidepressant | anaesthetic; anticonvulsant; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist |
| memantine | [no description available] | medium | 1 | 0 | adamantanes; primary aliphatic amine | antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist |
| benzenesulfonic acid | [no description available] | medium | 1 | 0 | benzenesulfonic acids | |
| fenclonine | [no description available] | medium | 1 | 0 | phenylalanine derivative | |
| dinoprostone | [no description available] | medium | 1 | 0 | prostaglandins E | human metabolite; mouse metabolite; oxytocic |
| indomethacin | [no description available] | medium | 1 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
| melatonin | [no description available] | medium | 1 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
| carbocyanines | [no description available] | medium | 1 | 0 | cyanine dye; organic iodide salt | fluorochrome |
| cannabichromene | [no description available] | medium | 1 | 0 | 1-benzopyran | |
| gpi 6150 | [no description available] | medium | 1 | 0 | ||
| lanthanum | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom; scandium group element atom | |
| bilirubin | [no description available] | medium | 1 | 0 | biladienes; dicarboxylic acid | antioxidant; human metabolite; mouse metabolite |
| iodoacetamide | [no description available] | medium | 2 | 0 | ||
| 15-deoxy-delta(12,14)-prostaglandin j2 | [no description available] | medium | 1 | 0 | prostaglandins J | electrophilic reagent; insulin-sensitizing drug; metabolite |
| prostaglandin d2 | [no description available] | medium | 1 | 0 | prostaglandins D | human metabolite; mouse metabolite |
| curcumin | [no description available] | medium | 2 | 0 | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
| fusidic acid | [no description available] | medium | 1 | 0 | 11alpha-hydroxy steroid; 3alpha-hydroxy steroid; alpha,beta-unsaturated monocarboxylic acid; steroid acid; steroid antibiotic; sterol ester | EC 2.7.1.33 (pantothenate kinase) inhibitor; Escherichia coli metabolite; protein synthesis inhibitor |
| chromonar | [no description available] | medium | 1 | 0 | coumarins | |
| cloricromen | [no description available] | medium | 1 | 0 | coumarins | |
| amitriptyline | [no description available] | medium | 1 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
| chitosan | [no description available] | medium | 1 | 0 | ||
| silver | [no description available] | medium | 1 | 0 | copper group element atom; elemental silver | Escherichia coli metabolite |
| 2,4-dinitrofluorobenzene sulfonic acid | [no description available] | medium | 1 | 0 | ||
| 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one | [no description available] | medium | 1 | 0 | ||
| substance p | [no description available] | medium | 1 | 0 | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent |
| pulmicort | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone | anti-inflammatory drug; bronchodilator agent; drug allergen |
| endothelin-1 | [no description available] | medium | 1 | 0 | ||
| dalteparin | [no description available] | medium | 1 | 0 | ||
| peroxynitrous acid | [no description available] | medium | 1 | 0 | nitrogen oxoacid | |
| celecoxib | [no description available] | medium | 1 | 0 | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| tamoxifen | [no description available] | medium | 1 | 0 | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |
| diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
| oxmetidine | [no description available] | medium | 1 | 0 | benzodioxoles; imidazoles; pyrimidone | anti-ulcer drug; H2-receptor antagonist |
| 4-phenolsulfonic acid | [no description available] | low | 0 | 0 | arenesulfonic acid | |
| 4-hydroxy-3-methoxybenzene-1-sulfonic acid | [no description available] | low | 0 | 0 | arenesulfonic acid; guaiacols | expectorant |
| pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | [no description available] | low | 0 | 0 | arenesulfonic acid; azobenzenes; methylpyridines; monohydroxypyridine; organic phosphate; pyridinecarbaldehyde | purinergic receptor P2X antagonist |
| 4-toluenesulfonic acid | [no description available] | low | 0 | 0 | arenesulfonic acid; toluenes | |
| ovex | [no description available] | low | 0 | 0 | arenesulfonic acid | |
| sulfosalicylic acid | [no description available] | low | 0 | 0 | arenesulfonic acid; benzoic acids; phenols | metabolite |
| 1,2-naphthoquinone-4-sulfonate | [no description available] | low | 0 | 0 | arenesulfonic acid; naphthalenone | colorimetric reagent |
| 4-chloromercuribenzenesulfonate | [no description available] | low | 0 | 0 | arenesulfonic acid; arylmercury compound | |
| azuletil | [no description available] | low | 0 | 0 | arenesulfonic acid; azulenes | anti-ulcer drug; thromboxane A2 antagonist |
| anthraquinone-2,6-disulfonate | [no description available] | low | 0 | 0 | anthraquinone; arenesulfonic acid | |
| bathocuproine disulfonate | [no description available] | low | 0 | 0 | arenesulfonic acid; phenanthrolines | chelator |
| 1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonic acid phenyl ester | [no description available] | low | 0 | 0 | arenesulfonic acid | |
| levoplast | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrobenzaldehyde | [no description available] | low | 0 | 0 | benzaldehydes; C-nitro compound | |
| parathion | [no description available] | low | 0 | 0 | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite |
| 3-nitropropionic acid | [no description available] | low | 0 | 0 | C-nitro compound | antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin |
| aristolochic acid i | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
| azathioprine | [no description available] | low | 0 | 0 | aryl sulfide; C-nitro compound; imidazoles; thiopurine | antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug |
| bay-k-8644 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester | |
| benefin | [no description available] | low | 0 | 0 | C-nitro compound; organofluorine compound; substituted aniline; tertiary amino compound | agrochemical; herbicide |
| dimetridazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | antiparasitic agent; antiprotozoal drug |
| etanidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles; monocarboxylic acid amide | alkylating agent; antineoplastic agent; prodrug; radiosensitizing agent |
| flunitrazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative |
| methyl parathion | [no description available] | low | 0 | 0 | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; genotoxin |
| metronidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic |
| nicardipine | [no description available] | low | 0 | 0 | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | |
| niclosamide | [no description available] | low | 0 | 0 | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor |
| nifedipine | [no description available] | low | 0 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
| nilutamide | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; C-nitro compound; imidazolidinone | androgen antagonist; antineoplastic agent |
| nimesulide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
| nimetazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; GABA modulator; sedative |
| nimodipine | [no description available] | low | 0 | 0 | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
| nisoldipine | [no description available] | low | 0 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester | |
| nitrazepam | [no description available] | low | 0 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative |
| nitrendipine | [no description available] | low | 0 | 0 | C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester | antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent |
| nizatidine | [no description available] | low | 0 | 0 | 1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound | anti-ulcer drug; cholinergic drug; H2-receptor antagonist |
| n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor |
| oxamniquine | [no description available] | low | 0 | 0 | aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound | |
| 4-nitrophenylacetic acid | [no description available] | low | 0 | 0 | C-nitro compound; phenylacetic acids | |
| ronidazole | [no description available] | low | 0 | 0 | C-nitro compound; carbamate ester; imidazoles | antiparasitic agent; antiprotozoal drug |
| trifluralin | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; C-nitro compound; substituted aniline | agrochemical; environmental contaminant; herbicide; xenobiotic |
| 4-nitroquinoline-1-oxide | [no description available] | low | 0 | 0 | C-nitro compound; quinoline N-oxide | carcinogenic agent |
| chloramphenicol | [no description available] | low | 0 | 0 | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
| niridazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; C-nitro compound | |
| nifenalol | [no description available] | low | 0 | 0 | C-nitro compound | |
| chloropicrin | [no description available] | low | 0 | 0 | C-nitro compound; one-carbon compound; organochlorine compound | antifungal agrochemical; fumigant insecticide; nematicide |
| quintozene | [no description available] | low | 0 | 0 | aromatic fungicide; C-nitro compound; pentachlorobenzenes | antifungal agrochemical |
| musk ambrette (artificial) | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-chloro-2-nitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound; monochlorobenzenes | |
| picryl chloride | [no description available] | low | 0 | 0 | C-nitro compound; monochlorobenzenes | allergen; epitope; explosive; hapten |
| picric acid | [no description available] | low | 0 | 0 | C-nitro compound | antiseptic drug; explosive; fixative |
| 2-nitro-4-methylaniline | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3,5-dinitrobenzoic acid | [no description available] | low | 0 | 0 | benzoic acids; C-nitro compound | |
| 5-nitro-2-toluidine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-chloronitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrobenzyl chloride | [no description available] | low | 0 | 0 | benzyl chlorides; C-nitro compound | mutagen |
| 4-nitroacetophenone | [no description available] | low | 0 | 0 | acetophenones; C-nitro compound | |
| tecnazene | [no description available] | low | 0 | 0 | aromatic fungicide; C-nitro compound; tetrachlorobenzene | antifungal agrochemical |
| 4-amino-2-nitrotoluene | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-amino-5-nitrothiazole | [no description available] | low | 0 | 0 | C-nitro compound; thiazoles | |
| naphthol yellow | [no description available] | low | 0 | 0 | C-nitro compound; naphthalenesulfonic acid; naphthols | histological dye |
| azomycin | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | antitubercular agent |
| 2-nitrobenzaldehyde | [no description available] | low | 0 | 0 | benzaldehydes; C-nitro compound | |
| 1-bromo-2,4-dinitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound; organobromine compound | |
| 3,5-dinitrosalicylic acid | [no description available] | low | 0 | 0 | C-nitro compound; monohydroxybenzoic acid | hapten |
| 3,5-dinitrotoluene | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-methyl-5-nitroimidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| 5-nitro-2-furaldehyde | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| 4-nitrophenyl acetate | [no description available] | low | 0 | 0 | C-nitro compound; phenyl acetates | |
| methylparaoxon | [no description available] | low | 0 | 0 | C-nitro compound | |
| dinobuton | [no description available] | low | 0 | 0 | C-nitro compound | |
| pyrrolnitrin | [no description available] | low | 0 | 0 | alkaloid; C-nitro compound; monochlorobenzenes; pyrroles | antifungal drug; bacterial metabolite |
| dinoterb | [no description available] | low | 0 | 0 | C-nitro compound; phenols | |
| 2,4-dinitrothiocyanatobenzene | [no description available] | low | 0 | 0 | C-nitro compound; thiocyanates | hapten; tolerogen |
| 2,4,6-trichlorophenyl 4-nitrophenyl ether | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; chlorobenzenes | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitroimidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| 2-(alpha-thenoylamino)-2-nitro-5-thiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; C-nitro compound | |
| nitroxoline | [no description available] | low | 0 | 0 | C-nitro compound; monohydroxyquinoline | antifungal agent; antiinfective agent; antimicrobial agent; renal agent |
| nitralin | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1,2-epoxy-3-(p-nitrophenoxy)propane | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; epoxide | |
| nimorazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| 4-chloro-7-nitrobenzofurazan | [no description available] | low | 0 | 0 | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome |
| ipronidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| ornidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles; organochlorine compound; secondary alcohol | antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope |
| oryzalin | [no description available] | low | 0 | 0 | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide |
| fenitrothion | [no description available] | low | 0 | 0 | C-nitro compound; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide |
| benzonidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles; monocarboxylic acid amide | antiprotozoal drug |
| N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimine | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| 3-nitro-1-propanol | [no description available] | low | 0 | 0 | C-nitro compound | |
| amoscanate | [no description available] | low | 0 | 0 | C-nitro compound; isothiocyanate; secondary amino compound | schistosomicide drug |
| profluralin | [no description available] | low | 0 | 0 | C-nitro compound | |
| dinitramine | [no description available] | low | 0 | 0 | C-nitro compound | |
| hc blue no. 2 | [no description available] | low | 0 | 0 | C-nitro compound | |
| fluchloralin | [no description available] | low | 0 | 0 | C-nitro compound | |
| butralin | [no description available] | low | 0 | 0 | C-nitro compound | |
| isopropalin | [no description available] | low | 0 | 0 | C-nitro compound | |
| pendimethalin | [no description available] | low | 0 | 0 | C-nitro compound; secondary amino compound; substituted aniline | agrochemical; environmental contaminant; herbicide |
| ethafluralin | [no description available] | low | 0 | 0 | C-nitro compound | |
| acifluorfen | [no description available] | low | 0 | 0 | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| bromethalin | [no description available] | low | 0 | 0 | C-nitro compound | |
| fomesafen | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| bmy 25067 | [no description available] | low | 0 | 0 | C-nitro compound; organic disulfide | antineoplastic agent |
| 2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| musk xylene | [no description available] | low | 0 | 0 | C-nitro compound | carcinogenic agent; explosive; fragrance |
| 4-nitrophenylalanine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrobenzyl bromide | [no description available] | low | 0 | 0 | benzyl bromides; C-nitro compound | allergen; sensitiser |
| nitarsone | [no description available] | low | 0 | 0 | C-nitro compound; organoarsonic acid | agrochemical; antiprotozoal drug |
| 5'-nitro-2'-propoxyacetanilide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| cinitapride | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 5-nitrouracil | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-nitrobenzyl alcohol | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrobenzyl alcohol | [no description available] | low | 0 | 0 | benzyl alcohols; C-nitro compound | xenobiotic metabolite |
| secnidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles; secondary alcohol | epitope |
| 4-nitrophenyl palmitate | [no description available] | low | 0 | 0 | C-nitro compound; hexadecanoate ester | |
| 4-nitrophenyl butyrate | [no description available] | low | 0 | 0 | butyrate ester; C-nitro compound | |
| 2-nitrophenylacetic acid | [no description available] | low | 0 | 0 | C-nitro compound; phenylacetic acids | |
| 4-nitrophenyl sulfate | [no description available] | low | 0 | 0 | aryl sulfate; C-nitro compound | human metabolite |
| 4-nitrophenyl-alpha-l-fucoside | [no description available] | low | 0 | 0 | alpha-L-fucoside; C-nitro compound | chromogenic compound |
| 4-nitrophenylglucuronide | [no description available] | low | 0 | 0 | beta-D-glucosiduronic acid; C-nitro compound | chromogenic compound |
| chloramphenicol stearate | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4,5-dimethoxy-2-nitrobenzaldehyde | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 4-nitrophenyl beta-d-xyloside | [no description available] | low | 0 | 0 | C-nitro compound; xyloside | chromogenic compound |
| fluazinam | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aminopyridine; C-nitro compound; chloropyridine; monochlorobenzenes; secondary amino compound | allergen; antifungal agrochemical; apoptosis inducer; environmental contaminant; xenobiotic |
| 2-nitropropanol | [no description available] | low | 0 | 0 | C-nitro compound | |
| aclonifen | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline | agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| 4-nitrophenyl beta-d-glucoside | [no description available] | low | 0 | 0 | beta-D-glucoside; C-nitro compound | chromogenic compound |
| 4-nitrophenyl alpha-glucoside | [no description available] | low | 0 | 0 | alpha-D-glucoside; C-nitro compound; monosaccharide derivative | chromogenic compound |
| bnps-skatole | [no description available] | low | 0 | 0 | aryl sulfide; bromoindole; C-nitro compound | reagent |
| nitrophenylgalactosides | [no description available] | low | 0 | 0 | beta-D-galactoside; C-nitro compound | chromogenic compound |
| 6-n-(2,4-dinitrophenyl)aminohexanoic acid | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-nitro-2-(1-piperidinyl)pyridine | [no description available] | low | 0 | 0 | C-nitro compound | |
| s-(4-nitrobenzyl)glutathione | [no description available] | low | 0 | 0 | C-nitro compound; organic sulfide; S-substituted glutathione | |
| 4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside | [no description available] | low | 0 | 0 | C-nitro compound; N-acetyl-beta-D-glucosaminide | chromogenic compound |
| miserotoxin | [no description available] | low | 0 | 0 | beta-D-glucoside; C-nitro compound | phytotoxin |
| aristolochic acid ii | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
| nitisinone | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; C-nitro compound; cyclohexanones; mesotrione | EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor |
| efonidipine | [no description available] | low | 0 | 0 | C-nitro compound; carboxylic ester; dihydropyridine; tertiary amino compound | |
| 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| pyrrolomycin a | [no description available] | low | 0 | 0 | antibiotic antifungal agent; C-nitro compound; organochlorine compound; pyrroles | antibacterial agent; bacterial metabolite |
| 2,8-dinitroimipramine | [no description available] | low | 0 | 0 | C-nitro compound; dibenzoazepine; tertiary amino compound | |
| 7-nitrobenzoxadiazole-6-aminohexanoic acid | [no description available] | low | 0 | 0 | benzoxadiazole; C-nitro compound; epsilon-amino acid; secondary amino compound | fluorochrome |
| aristolochic acid D | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin |
| ag 3-5 | [no description available] | low | 0 | 0 | C-nitro compound | |
| thymidine 5'-4-nitrophenyl phosphate | [no description available] | low | 0 | 0 | aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | |
| aristolochic acid c | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
| mesotrione | [no description available] | low | 0 | 0 | aromatic ketone; beta-triketone; C-nitro compound; sulfone | carotenoid biosynthesis inhibitor; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; environmental contaminant; herbicide; xenobiotic |
| 4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-(4-nitrophenyl)-2-phenoxyacetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| rubitecan | [no description available] | low | 0 | 0 | C-nitro compound; delta-lactone; pyranoindolizinoquinoline; semisynthetic derivative; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug |
| 2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | C-nitro compound | |
| 7-nitro-5-indeno[1,2-b]pyridinone | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-(6-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| (3,5-dimethyl-1-pyrazolyl)-(2-ethyl-4-nitro-3-pyrazolyl)methanone | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(4-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| 4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(2-fluoro-5-nitrophenyl)-2,2-dimethylbutanamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-(2-methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 2-[[cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-(5-tert-butyl-3-isoxazolyl)-3-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-methyl-2-(4-nitrophenyl)-5-thiazolecarboxylic acid | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-(3,5-dimethyl-4-nitro-1-pyrazolyl)butanoic acid | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| stattic | [no description available] | low | 0 | 0 | 1-benzothiophenes; C-nitro compound; sulfone | antineoplastic agent; radiosensitizing agent; STAT3 inhibitor |
| 2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N2-tert-butyl-6-ethoxy-N4-(4-nitrophenyl)-1,3,5-triazine-2,4-diamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-methyl-N-[5-(4-nitrophenyl)sulfonyl-2-thiazolyl]pentanamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-[(2-ethyl-1-piperidinyl)-sulfanylidenemethyl]-4-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-[[3-methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(4-chloro-3-nitrophenyl)-3-phenylbutanamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
| 2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| carnidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| 3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| 3-nitro-N'-(2,4,6-trichlorophenyl)benzohydrazide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-(2,2-dimethyl-4-oxanyl)-4-(4-nitrophenyl)thiazole | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(4-fluorophenyl)-5-nitro-2-pyridinamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide | [no description available] | low | 0 | 0 | C-nitro compound; thiazoles | |
| 3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] ester | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| 2-[(5-amino-1H-1,2,4-triazol-3-yl)thio]-N-(2-bromo-4-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrophenylhydrazine | [no description available] | low | 0 | 0 | C-nitro compound; phenylhydrazines | mutagen |
| 4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrocatechol | [no description available] | low | 0 | 0 | C-nitro compound; catechols | human xenobiotic metabolite; lipoxygenase inhibitor |
| 1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| nefurthiazole | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| 2-[(4-aminophenyl)thio]-N-(3-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-[4-(2-hydroxyethylamino)-3-nitrophenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-[[6-amino-2-(3-methylanilino)-5-nitro-4-pyrimidinyl]amino]ethanol | [no description available] | low | 0 | 0 | C-nitro compound | |
| N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 3-nitro-N-(2-phenylethyl)-2-pyridinamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-(4-nitrophenyl)-4-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2,4-dinitrophenylhydrazine | [no description available] | low | 0 | 0 | C-nitro compound; phenylhydrazines | reagent |
| 3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-methyl-2-[[(4-nitrophenyl)-oxomethyl]hydrazo]-4-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| 5-nitro-2-thiophenecarboxylic acid [1-[(3,5-dichloro-2-pyridinyl)amino]-1-oxopropan-2-yl] ester | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| N-[2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl]-4-nitroaniline | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-nitrocaramiphen | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-[(3-methyl-5-nitro-4-imidazolyl)amino]phenol | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
| N2-(3-methylphenyl)-6-(4-morpholinyl)-5-nitropyrimidine-2,4-diamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| sb 415286 | [no description available] | low | 0 | 0 | C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline | antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent |
| N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide | [no description available] | low | 0 | 0 | C-nitro compound; secondary carboxamide; tertiary carboxamide; trifluoroacetamide | |
| 2-[[6-amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol | [no description available] | low | 0 | 0 | C-nitro compound | |
| 4-(3-chlorophenyl)sulfonyl-N-cyclohexyl-N-methyl-3-nitrobenzamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 6-(2-methyl-1-piperidinyl)-5-nitro-4-pyrimidinamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-(5-nitro-2-thiophenyl)piperidine | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| N-[2-(2,4,6-trinitrophenyl)ethyl]aniline | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-nitro-4-phenylenediamine | [no description available] | low | 0 | 0 | C-nitro compound; primary amino compound | |
| N2-(2-furanylmethyl)-5-nitro-6-(1-pyrrolidinyl)pyrimidine-2,4-diamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone | [no description available] | low | 0 | 0 | C-nitro compound | |
| N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| 2-(2,3-dihydroxypropylamino)-5-nitro-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-[(2-nitrophenyl)thio]-1-cyclooctanone | [no description available] | low | 0 | 0 | C-nitro compound | |
| 5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| N2-(2-furanylmethyl)-6-(3-methyl-1-piperidinyl)-5-nitropyrimidine-2,4-diamine | [no description available] | low | 0 | 0 | C-nitro compound | |
| N'-(4-nitrophenyl)-9-oxo-3-bicyclo[3.3.1]nonanecarbohydrazide | [no description available] | low | 0 | 0 | C-nitro compound | |
| alsterpaullone | [no description available] | low | 0 | 0 | C-nitro compound; caprolactams; organic heterotetracyclic compound | anti-HIV-1 agent; antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor |
| 2-(4-fluoro-3-nitrophenyl)-4,4-dimethyl-5H-oxazole | [no description available] | low | 0 | 0 | C-nitro compound | |
| 1,2-diamino-4-nitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound; primary amino compound | |
| N'-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]-4-nitrobenzohydrazide | [no description available] | low | 0 | 0 | C-nitro compound | |
| furylfuramide | [no description available] | low | 0 | 0 | acrylamides; C-nitro compound; nitrofuran antibiotic; primary carboxamide | |
| cilnidipine | [no description available] | low | 0 | 0 | 2-methoxyethyl ester; C-nitro compound; dihydropyridine | antihypertensive agent; calcium channel blocker; cardiovascular drug |
| ro 61-8048 | [no description available] | low | 0 | 0 | C-nitro compound | |
| meptyldinocap | [no description available] | low | 0 | 0 | C-nitro compound; enoate ester | |
| l796778 | [no description available] | low | 0 | 0 | benzenes; C-nitro compound; L-lysine derivative; L-phenylalanine derivative; methyl ester; oligopeptide; secondary carboxamide; ureas | somatostatin receptor agonist |
| amocarzine | [no description available] | low | 0 | 0 | C-nitro compound; N-methylpiperazine; secondary amino compound; thioureas | antinematodal drug |
| nitrovin | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| dihydroxymethylfuratrizine | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| nifurpirinol | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| azanidazole | [no description available] | low | 0 | 0 | C-nitro compound; imidazoles | |
| aureothin | [no description available] | low | 0 | 0 | 4-pyranones; C-nitro compound; ketene acetal; olefinic compound; oxolanes | antibacterial agent; antifungal agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor |
| nidroxyzone | [no description available] | low | 0 | 0 | C-nitro compound; furans | |
| nifurzide | [no description available] | low | 0 | 0 | C-nitro compound; thiophenes | |
| abt-737 | [no description available] | low | 0 | 0 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
| 5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine | [no description available] | low | 0 | 0 | 1,3-thiazoles; C-nitro compound; organic sulfide; primary amino compound; thiadiazoles | antibacterial agent; c-Jun N-terminal kinase inhibitor |
| [4-(2-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | C-nitro compound | |
| 2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate | [no description available] | low | 0 | 0 | C-nitro compound; spiroketal | antagonist |
| 2-(4-morpholinyl)-N'-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide | [no description available] | low | 0 | 0 | C-nitro compound | |
| N'-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide | [no description available] | low | 0 | 0 | C-nitro compound | |
| ML-210 | [no description available] | low | 0 | 0 | C-nitro compound; diarylmethane; isoxazoles; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; tertiary carboxamide | antineoplastic agent; EC 1.11.1.9 (glutathione peroxidase) inhibitor; ferroptosis inducer; prodrug |
| abt-199 | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
| chir 98014 | [no description available] | low | 0 | 0 | aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound | antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator |
| acenocoumarol | [no description available] | low | 0 | 0 | C-nitro compound; hydroxycoumarin; methyl ketone | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor |
| 8-nitroguanosine 3',5'-cyclic monophosphate | [no description available] | low | 0 | 0 | 3',5'-cyclic purine nucleotide; C-nitro compound | biomarker; Brassica napus metabolite; human metabolite; signalling molecule |
| Article | Year |
|---|---|
| Aromatic-aromatic interaction of amitriptyline: implication of overdosed drug detoxification. Journal of pharmaceutical sciences, Volume: 94, Issue: 2 | 2005 |
| Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats. Alimentary pharmacology & therapeutics, Volume: 15, Issue: 10 | 2001 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |